OA

Oaktree Acquisition Corp. III Life Sciences

OACC·NASDAQ

$10.63

-0.19%
Financial ServicesShell Companies

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

At a Glance

Live Snapshot
Market Cap$261.31M
EPS0.3000
P/E Ratio35.43
Earnings Date

oacc

Selling, General and Administrative Expenses

Last Annual Value

1.20M

3-Year CAGR

1094%

5-Year CAGR

343%

10-Year CAGR

110%

OA

Oaktree Acquisition Corp. III Life Sciences Competitors Analysis of Selling, General and Administrative Expenses

OACC · NASDAQ
CompanySelling, General and Administrative Expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
1.20M
N/AN/AN/A 
546.00K
N/AN/AN/A
2.23M
-61.5%N/AN/A
2.92M
N/AN/AN/A
2.21M
N/AN/AN/A
1.83M
733.6%N/AN/A
1.04M
70.0%N/AN/A
1.94M
N/AN/AN/A
0.00
N/AN/AN/A
1.67M
N/AN/AN/A
OA

Oaktree Acquisition Corp. III Life Sciences Fair Value Envelope

OACC · NASDAQ

Our analysis suggests that OACC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.63, this represents a potential HIDDEN relative to our calculated worth for Oaktree Acquisition Corp. III Life Sciences.

Intrinsic Value
Current Price: $10.63